738 results on '"She, Zhi-Gang"'
Search Results
2. Artificial sweeteners and risk of incident cardiovascular disease and mortality: evidence from UK Biobank
3. Gastrodin inhibits prostate cancer proliferation by targeting canonical Wnt/β-catenin signaling pathway
4. Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome
5. Histone demethylase KDM1A promotes hepatic steatosis and inflammation by increasing chromatin accessibility in NAFLD
6. Major lipids and lipoprotein levels and risk of blood pressure elevation: a Mendelian Randomisation study
7. Recent updates on targeting the molecular mediators of NAFLD
8. Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients
9. The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19
10. Kidney Function Indicators Predict Adverse Outcomes of COVID-19
11. Network-based analysis identifies key regulatory transcription factors involved in skin aging
12. Long-term exposure to air pollution and increased risk of atrial fibrillation prevalence in China
13. Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19
14. Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
15. In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
16. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
17. Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma
18. The predictions of seven cancers burden attributed to high fasting plasma glucose from 2020 to 2030
19. Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data
20. Global death burden and attributable risk factors of peripheral artery disease by age, sex, SDI regions, and countries from 1990 to 2030: Results from the Global Burden of Disease study 2019
21. NAFLD as a continuous driver in the whole spectrum of vascular disease
22. Risk factors for COVID-19 progression and mortality in hospitalized patients without pre-existing comorbidities
23. Multispecies transcriptomics identifies SIKE as a MAPK repressor that prevents NASH progression
24. Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species
25. TMBIM1 is an inhibitor of adipogenesis and its depletion promotes adipocyte hyperplasia and improves obesity-related metabolic disease
26. A kinome screen reveals that Nemo-like kinase is a key suppressor of hepatic gluconeogenesis
27. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
28. Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis
29. TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation
30. Three new isocoumarin derivatives from the mangrove endophytic fungus Penicillium sp. YYSJ-3
31. The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy
32. A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries.
33. New p32/gC1qR Ligands for Targeted Tumor Drug Delivery
34. Gastrodin inhibits prostate cancer proliferation by targeting canonical Wnt/β-catenin signaling pathway
35. Long-Term Exposure to Fine Particulate Constituents and Vascular Damage in a Population with Metabolic Abnormality in China
36. Tumor-specific macrophage targeting through recognition of retinoid X receptor beta
37. Fabricating a hepatocyte-targeted fullerene derivative as a new lipid droplet regulator
38. STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy
39. Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality
40. Ablation of NG2 proteoglycan leads to deficits in brown fat function and to adult onset obesity.
41. The Transition of Cardiovascular Disease Risks from NAFLD to MAFLD
42. Prevalence and trend of atrial fibrillation and its associated risk factors among the population from nationwide health check-up centers in China, 2012–2017
43. Targeting peroxisome proliferator‐activated receptor γ proteasomal degradation by magnolol is a potential avenue for adipogenesis‐mediated metabolic homeostasis
44. Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population
45. Ca2+-Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production
46. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality
47. Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases
48. The rising death burden of atrial fibrillation and flutter in low-income regions and younger populations
49. The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
50. The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.